Mayne Pharma FY revenue A$383.7 million, down 6%
Mayne Pharma reported FY revenue of A$383.7 million, down 6%.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Mayne Pharma reported FY revenue of A$383.7 million, down 6%.